Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase Activity

ABSTRACT Janus kinases are essential for signal transduction by a variety of cytokine receptors and when inappropriately activated can cause hematopoietic disorders and oncogenesis. Consequently, it can be predicted that the interaction of the kinases with receptors and the events required for activation are highly controlled. In a screen to identify phosphorylation events regulating Jak2 activity in EpoR signaling, we identified a mutant (Jak2-Y613E) which has the property of being constitutively activated, as well as an inactivating mutation (Y766E). Although no evidence was obtained to indicate that either site is phosphorylated in signaling, the consequences of the Y613E mutation are similar to those observed with recently described activating mutations in Jak2 (Jak2-V617F and Jak2-L611S). However, unlike the V617F or L611S mutant, the Y613E mutant requires the presence of the receptor but not Epo stimulation for activation and downstream signaling. The properties of the Jak2-Y613E mutant suggest that under normal conditions, Jak2 that is not associated with a receptor is locked into an inactive state and receptor binding through the FERM domain relieves steric constraints, allowing the potential to be activated with receptor engagement.

[1]  Xinming Cai,et al.  Structural Basis for the Autoinhibition of Focal Adhesion Kinase , 2007, Cell.

[2]  J. Ihle,et al.  Jak2: normal function and role in hematopoietic disorders. , 2007, Current opinion in genetics & development.

[3]  T. Matsuda,et al.  Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2 , 2006, The EMBO journal.

[4]  J. Ihle,et al.  Two Domains of the Erythropoietin Receptor Are Sufficient for Jak2 Binding/Activation and Function , 2006, Molecular and Cellular Biology.

[5]  O. Silvennoinen,et al.  Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active State , 2006, Molecular and Cellular Biology.

[6]  M. G. Myers,et al.  Phosphorylation of Jak2 on Ser523 Inhibits Jak2-Dependent Leptin Receptor Signaling , 2006, Molecular and Cellular Biology.

[7]  A. Stensballe,et al.  Phosphorylation of JAK2 at Serine 523: a Negative Regulator of JAK2 That Is Stimulated by GrowthHormone and Epidermal Growth Factor , 2006, Molecular and Cellular Biology.

[8]  M. G. Myers,et al.  Phosphorylation of Jak2 on Ser523 InhibitsJak2-Dependent Leptin ReceptorSignaling , 2006, Molecular and Cellular Biology.

[9]  H. Lodish,et al.  Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Stefan N. Constantinescu,et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.

[11]  Sandra A. Moore,et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.

[12]  M. Tremblay,et al.  Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. , 2005, Current opinion in cell biology.

[13]  D. Barber,et al.  Turning cells red: signal transduction mediated by erythropoietin. , 2005, Trends in cell biology.

[14]  Y. Sekine,et al.  Determination of the transphosphorylation sites of Jak2 kinase. , 2004, Biochemical and biophysical research communications.

[15]  H. Steen,et al.  Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity , 2004, Molecular and Cellular Biology.

[16]  M. G. Myers,et al.  Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling , 2004, Molecular and Cellular Biology.

[17]  J. O’Shea,et al.  Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-Bβ , 2004, Molecular and Cellular Biology.

[18]  Mauno Vihinen,et al.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. , 2003, Molecular biology of the cell.

[19]  Fabrizio Giordanetto,et al.  Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. , 2002, Protein engineering.

[20]  D. Barford,et al.  TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.

[21]  J. Roberts,et al.  Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. , 2001, Molecular cell.

[22]  J. Ihle,et al.  The distal region and receptor tyrosines of the Epo receptor are non‐essential for in vivo erythropoiesis , 2001, The EMBO journal.

[23]  Josef M. Penninger,et al.  CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling , 2001, Nature.

[24]  A. Yoshimura,et al.  The JAK‐binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop , 1999, The EMBO journal.

[25]  J. Marine,et al.  Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[26]  A. Cumano,et al.  Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.

[27]  R Berger,et al.  A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.

[28]  T. Taniguchi,et al.  The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  I. Kerr,et al.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop , 1997, Molecular and cellular biology.

[30]  S. Pestka,et al.  A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses , 1997, Molecular and cellular biology.

[31]  J. Ihle,et al.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response , 1996, Molecular and cellular biology.

[32]  I. Sakai,et al.  Regions of the JAK2 Tyrosine Kinase Required for Coupling to the Growth Hormone Receptor (*) , 1995, The Journal of Biological Chemistry.

[33]  A. Kraft,et al.  The Amino-terminal Portion of the JAK2 Protein Kinase Is Necessary For Binding and Phosphorylation of the Granulocyte-Macrophage Colony-stimulating Factor Receptor β Chain (*) , 1995, The Journal of Biological Chemistry.

[34]  N. Perrimon,et al.  Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. , 1995, The EMBO journal.

[35]  H. Luo,et al.  An amino acid substitution in the Drosophila hopTum‐l Jak kinase causes leukemia‐like hematopoietic defects. , 1995, The EMBO journal.

[36]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.